Difficulty: Medium
Average Score: 78%
Practice
Which of the following disadvantages does not limit using benzodiazepines as antianxiety agents?
Correct answer
B
Rationale
In the context of safety pharmacology across the lifespan, understanding the limitations of benzodiazepines as antianxiety agents is crucial for safe prescribing practices. Option B, "A high risk of drug interactions based on liver enzyme induction," is the correct answer because benzodiazepines are not primarily metabolized by liver enzymes that induce or inhibit other drugs. This reduces the likelihood of significant drug interactions compared to other medications metabolized by these enzymes.
Option A, "Tendency to develop psychologic dependence," is a disadvantage of benzodiazepines as they can lead to tolerance and dependence, especially with long-term use. This limitation is significant across the lifespan, particularly in older adults and individuals with a history of substance abuse.
Option C, "Synergic CNS depression with concomitant use of other drugs," is a concern with benzodiazepines due to their central nervous system depressant effects. This risk is heightened in the elderly and individuals taking other medications that also depress the CNS, increasing the potential for adverse effects like sedation and respiratory depression.
Option D, "The formation of active metabolites," can be a disadvantage as active metabolites may accumulate in the body, leading to prolonged drug effects and increased risk of side effects, especially in individuals with impaired drug metabolism or renal function.
Educationally, understanding the limitations of benzodiazepines in terms of drug interactions, dependence potential, CNS depression, and metabolites is essential for healthcare providers to make informed decisions when prescribing these agents, especially when considering the safety and well-being of patients across different stages of life.
Option A, "Tendency to develop psychologic dependence," is a disadvantage of benzodiazepines as they can lead to tolerance and dependence, especially with long-term use. This limitation is significant across the lifespan, particularly in older adults and individuals with a history of substance abuse.
Option C, "Synergic CNS depression with concomitant use of other drugs," is a concern with benzodiazepines due to their central nervous system depressant effects. This risk is heightened in the elderly and individuals taking other medications that also depress the CNS, increasing the potential for adverse effects like sedation and respiratory depression.
Option D, "The formation of active metabolites," can be a disadvantage as active metabolites may accumulate in the body, leading to prolonged drug effects and increased risk of side effects, especially in individuals with impaired drug metabolism or renal function.
Educationally, understanding the limitations of benzodiazepines in terms of drug interactions, dependence potential, CNS depression, and metabolites is essential for healthcare providers to make informed decisions when prescribing these agents, especially when considering the safety and well-being of patients across different stages of life.